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The activation of dendritic cells (DCs) has profound implications and governs the
control of adaptive immunity. However, long-term activation might drive exhaustion
of immune cells and negatively affect functionality. Here, long-term vs. short-term
exposure to bacterial lipopolysaccharide and interferon (IFN)γ was evaluated on
human monocyte-derived DCs. Long-term activated DC1s began to undergo apoptosis
concomitant with a profound TAM-receptor and efferocytosis-dependent induction of
interleukin (IL)-10. Whereas, levels of IL-12p70 and IL-10 were positively correlated upon
short-term activation, an inverse association occured upon long-term activation and,
while short-term activated CD1a+ DCs were main producers of IL-12p70, CD1a− DCs
were the main fraction that underwent apoptosis and released IL-10 upon long-term
activation. Moreover, pre-apoptotic long-term activated DCs were no longer able to
activate alloreactive IFNγ-responsive T cells present in peripheral blood mononuclear
cells from healthy volunteers. The IFNγ response was mediated by IL-12p70, as a
strong reduction in IFNγ was observed following blockade with an IL-12p70 neutralizing
antibody. Finally, multiplex analysis of DC supernatants revealed a particular pattern of
proteins associated with apoptosis, cancer and chronic inflammation partly overlapping
with gold standard DCs well-known for their inability to secrete IL-12p70. In conclusion,
long-term activated DC1s significantly changed their profile toward a non-functional,
tumor-promoting and anti-inflammatory phenotype.
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INTRODUCTION
Dendritic cells (DCs) are antigen-presenting cells that primarily process and present antigens to
T cells. As such, DCs bridge the innate and adaptive immune system and play a vital role in
generation of both immunity and tolerance (1). Immature DCs are specialized in antigen uptake
and processing. They are activated by pathogen-derived molecular patterns or danger-associated
molecular patterns on dying, stressed, or injured host cells resulting in inflammation and perturbed
tissue homeostasis (2). Lipopolysaccharide (LPS) constitutes a classical pathogen-derivedmolecular
pattern activating DCs via Toll-Like receptor 4 (3). Strong synergy is provided by interferon (IFN)γ
Carstensen et al. Long-Term Inflammation Affects Dendritic Cells
released from e.g., innate lymphocytes such as NK, NKT, or
Gamma Delta (γδ) T Cells driving release of inflammatory
cytokines including interleukin (IL)-12p70 (4), which control
IFNγ-dependent adaptive immunity in conditions of viral
infection and cancer (5). However, long-term exposure to
mediators of acute inflammation might signify a transition into
chronic inflammation and could be detrimental in the context of
tumor-specific adaptive immunity. As such, strong evidence links
inflammation to development of cancer, primarily involving the
transcription factor nuclear factor-κB and signal transducers and
activators of transcription 3 (2).
As an in vitro model, monocyte-derived DCs (MoDCs)
are relevant counterparts of monocyte-derived inflammatory
DCs found in vivo during disease-associated conditions of
inflammation whereas current models are less optimal at
studying homeostasis (6, 7). Upon activation, MoDC derived
cytokines such as tumor necrosis factor (TNF)α, IL-6, IL-10
and IL-12p70 plateau from about 12–48 h post activation with
LPS alone or LPS plus IFNγ (8). Looking at mRNA levels,
TNFα and IL-6 peak around 3 h followed by IL-12p35 and
p40 around 8 h and IL-10 around 18 h. Intracellular cytokine
staining confirm that IL-12p70 is produced around 18 h as
opposed to 42 h post activation (9) thus concluding that cytokine
production halts approximately 24 h after initiated activation.
To our knowledge no other studies compared the phenotype
and functionality of long-term (>48 h) vs. short-term activated
MoDCs. In contrast, several studies compared various types of
activation cocktails comprising either inflammatory mediators
alone, most prominently the gold standard DC cocktail (sDC;
TNFα, IL-1β, IL-6, and PGE2) (10) or cocktails employing a
mixture of Toll-Like receptor agonists combined with interferons
(11–13). In addition, it is described how MoDCs constitute a
heterogenous population of cells most profoundly as examplified
by CD1a+ and CD1a− subfractions (7, 14).
Long-term activation of MoDCs could be a relevant model
to study the in vivo situation of chronic inflammation elicited
by viral infection or cancer. To test this, MoDCs were activated
with LPS and IFNγ (Type 1 DCs; DC1) for 1 (18 h), 2, 3, or
4 days, and compared with immature or 18 h activated gold
standard (s)DCs.We performed extensive analysis on DC culture
supernatants and tested the ability of long-term vs. short-term
activated DCs to induce alloreactive cell activation. Long-term
inflammatory activation caused a striking change from pro- to
anti-inflammatory cytokines concomitant with induction of DC
apoptosis and inability to activate alloreactive IFNγ-responsive T
cells. Furthermore, a striking pattern of proteins associated with
apoptosis and chronic inflammation partly overlapped with sDCs
well-known for their inability to secrete IL-12p70.
MATERIALS AND METHODS
Media and Reagents
All cell cultures were performed in complete medium consisting
of RPMI 1640 medium supplemented with 10% fetal bovine
serum and 1% penicillin/streptomycin (all from Gibco). Cell
cultures were maintained at 37◦C in a humidified atmosphere of
5% CO2. The following reagents were used for generation and
activation of DCs: Recombinant human GM-CSF (PeproTech),
IL-4 (PeproTech), IFNγ (PeproTech), TNFα (PeproTech), IL-
1β (PeproTech), IL-6 (PeproTech), LPS from Escherichia coli
serotype O55:B5 (Sigma-Aldrich) and PGE2 (Sigma-Aldrich).
Generation and Activation of DCs
Monocyte-derived immature DCs were either produced in house
from buffy coats or were optained as a kind gift from M.W.
Pedersen and H.B. Grav, Symphogen A/S, Denmark. Immature
DCs were generated from monocytes purified from PBMCs by
positive selection employing CD14-reactive magnetic-activated
cell sorting beads (Miltenyi Biotech). After 4–7 days in culture
with 20 ng/mL GM-CSF and IL-4, iDCs were harvested by
vigorous pipetting, washed and stored at −140◦C. In select
experiments, iDCs were stained for CD1a expression and sorted
into CD1a+ and CD1a− fractions on a MACSQuant Tyto Cell
Sorter (curtesy of Olof Berggren, Miltenyi Biotec). Prior to
activation, thawed iDCs were rested for 1–4 days in complete
medium with 20 ng/mL GM-CSF and IL-4 in 24-well plates
in 1 mL/well at a density of 0.5 × 106 cells/mL. In selected
experiments, iDCs numbers and volumes were scaled down
two- or four-fold to accommodate to 48-well or 96-well plates.
To induce activation, iDCs were stimulated with either the
DC1 maturation cocktail (LPS, 1µg/mL + IFNγ, 1,000 U/mL)
for 1 (18 h), 2, 3, or 4 days or the gold standard DC (sDC)
activation cocktail (TNFα, 1,000 U/mL + IL-1β, 1,000 U/mL
+ IL-6, 1,000 U/mL + PGE2 1µg/mL) for 18 h. Additionally,
four-day activated DCs were incubated with Pan-TAM Tyrosine
Kinase Inhibitor BMS-777607 (10µM, Selleck Chemicals) and/or
efferocytosis inhibitor GSK-650394 (5µM, Sigma-Aldrich). DC
culture supernatants were harvested for cytokine measurements
and DCs were washed before added to a mixed lymphocyte
reaction (MLR) or stained for analysis by flow cytometry.
PBMC and T Cell Isolation
PBMCs were isolated from buffy coats obtained from healthy
volunteers by density gradient centrifugation using Lymphoprep
(Nycomed). Prior to being set up in a MLR, PBMCs were rested
overnight in a Falcon tube positioned at a slant of 5 degrees
above horizontal and the tube cap loosened in order to allow gas
exchange. In selected experiments, CD4+ or CD8+ T cells were
purified from PBMCs by positive selection. Briefly, according
to the manufacturer’s instructions, PBMCs were incubated with
anti-CD4 or anti-CD8 conjugated magnetic beads in PBS with
0.5% fetal bovine serum and 2mM EDTA. After washing the
cells, they were loaded onto charged LS columns (Miltenyi
Biotech) that were subsequently washed three times. The magnet
was removed and labeled CD4+ or CD8+ T cells were eluted.
The purity of each isolated T cell population was evaluated by
flow cytometry.
Mixed Lymphocyte Reaction
MoDCs were activated as described above. Overnight rested
PBMCs were counted under a hemocytometer using the trypan
blue exclusion test. DCs were harvested, washed and set
up with allogeneic PBMCs or isolated T cells at a ratio
of 1:10 in quadruplets in 96-well round-bottom plates to a
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final volume of 200 µL/well. If indicated, 10µg/mL anti-IL-
12p70 (R&D Systems) or 10 ng/mL recombinant human IL-
12p70 (PeproTech) were added to the co-cultures on day
zero. After 5 days, the MLR supernatants were harvested for
cytokine detection.
Cytokine Measurements
The IFNγ, IL-12p70, IL-12p40, IL-10, IL-17A, IL-23, TNFα, and
IL-6 levels in the DC andMLR supernatants weremeasured using
commercial ELISA kits (all from Invitrogen except IL-12p40
from Biolegend) according to the manufacturer’s instructions.
Briefly, MaxiSorp plates were coated with the respective capture
antibody incubating overnight at 4◦C. The remaining procedure
was performed at room temperature and washing was performed
between each successive step with ELISA wash buffer (PBS with
0.05% Tween 20, Sigma-Aldrich). After blocking the plates for
1 h with commercial ELISA diluent containing bovine serum,
the plates were incubated with samples and standards for
2 h. Subsequently, the respective biotin-conjugated detection
antibody was added and incubated for 1 h followed by addition of
streptavidin-horseradish peroxidase incubating for 30min. Color
was developed using 3,3
′
,5,5
′
-tetramethylbenzidine substrate and
the reaction was stopped after 10–15min with 1M phosphoric
acid. Absorption was measured at 450 nm and 570 nm on an
EpochMicroplate Spectrophotometer (BioTek Instruments). The
cytokine concentrations in the samples were calculated based
on the resulting standard curves in Gen5 software (BioTek
Instruments). The levels of IFNγ, IL-12p70, IL-12p40, IL-10, IL-
17A, IL-23, TNFα, and IL-6 were detected with a lower sensitivity
of 156, 7.8, 312, 94, 8, 32, 16, and 6.3 pg/mL, respectively.
DC Staining for Flow Cytometry
Prior to staining, cells were washed in FACS buffer [PBS,
0.05% sodium azide with 0.5% bovine serum albumin (Sigma-
Aldrich)]. Both during and after the staining procedure, cells
were kept cold and in the dark. To be able to discriminate
between live and dead cells in the subsequent analysis, cells were
incubated with LIVE/DEAD Fixable Near-IR Stain (Invitrogen)
according to manufacturer’s instructions. DCs were additionally
incubated with human IgG immunoglobulin (20µg/mL, Kiovig
Baxter) to block Fc receptors. The following fluorochrome
labeled monoclonal antibodies were used for staining: anti-
CD80 (L307.4, BD Pharmingen) and anti-CD86 (2331, BD
Pharmingen). Cells were fixed in 1% paraformaldehyde and
acquired within 5 days on a BD FACSCanto II (BD Biosciences).
Unstained DCs were included in the analysis and used for
calculating the mean fluorescence intensity (MFI) ratios between
stained and unstained samples. Single-stained BD ComBead
Plus compensation particles (BD Biosciences) were used for
compensation. Data were analyzed using BD FACSDiva software
version 8.0.2 (BD Biosciences).
DC Apoptosis Detection
DCs were washed in FACS buffer and resuspended in Annexin
V binding buffer (BioLegend). Subsequently, cells were stained
with FITC-conjugated Annexin V and 7-AAD (both BioLegend)
for 15min at room temperature and acquired immediately after
on a BD FACSCantoII.
Protein Screening Using Proximity
Extension Assay (PEA)
The Proximity Extension Assay (PEA) technology is a 92-
plex immuno-PCR method enabling large-scale multiplex
screening of protein biomarkers in targeted protein panels.
The PEA technology uses two paired oligonucleotide-conjugated
antibodies as probe for each protein. When a pair of probes
recognize and bind to a common target protein (dual binding),
the DNA oligonucleotides are brought in proximity and can
hybridize, allowing enzymatic DNA polymerization to produce
a new amplifiable DNA molecule (amplicon). The amplicon is
subsequently detected and quantified using microfluidic real-
time PCR. The technology reports relative protein values,
allowing comparison between groups of samples. The samples
were thawed at 4◦C, vortexed and spun down at 400× g at 1min.
One microliter of supernatant was added to 3 µL incubation mix
in a 96-well plate, with each well containing 92 pairs of probes
(A- and B-probes), incubation solution and incubation stabilizer.
The plate was incubated at 4◦C overnight (16–22 h). The next
day 96 µL extension mix containing PEA solution, PEA enzyme
and PCR polymerase was added to each well. The plate was
vortexed thoroughly, spun down and transferred to the thermal
cycler (Veriti 96 well Thermal Cycler, Applied Biosystems) for an
initial DNA extension at 50◦C for 20min followed by 17 cycles
of DNA amplification. The final step in the protocol quantifies
the DNA amplicons for each protein using the Fluidigm Biomark
system (Fluidigm, South San Francisco, CA, USA). The plate
with extension products was vortexed and spun down. In a new
plate, 2.8 µL of each extension product was mixed with 7.2 µL
detection mix consisting of detection solution, detection enzyme
and PCR polymerase. A 96.96 Dynamic Array Integrated Fluidic
Circuit (Fluidigm) was prepared and primed according to the
manufacturer’s instructions. The plate with samples was vortexed
thoroughly and spun down. From the sample plate 5 µL was
loaded into the right side of the primed 96.96 IFC. From the
primer plate the unique primer pairs for each protein were loaded
into the left side of the 96.96 IFC.
The PEA readout is a relative quantification of protein
abundance measured in Normalized Protein Expression (NPX),
which is an arbitrary unit on log2 scale where a high NPX
corresponds to a high protein abundance. NPX-values are
calculated from cycle threshold (Ct) values exported from the
Fluidigm Real-Time PCR Analysis software (Fluidigm, South
San Francisco, CA, USA) using NPX Manager software (Olink
Proteomics, Sweden). For each assay, protein concentration
detection limit (pg/mL), lower limit of quantification (LLOQ)
and upper limit of quantification ULOQ) are reported in the
validation data for each protein biomarker panel. The detection
limit is calculated as three times the standard deviation over the
background signal.
Statistical and Biocomputational Analysis
Data were analyzed with GraphPad Prism 8 (GraphPad
Software). Two-way ANOVA with Tukey’s post-hoc or Dunnett’s
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multiple comparisons test was performed to determine the
statistical significance between groups, where ∗∗∗∗p ≤ 0.0001,
∗∗∗p ≤ 0.001, ∗∗p ≤ 0.01, ∗p ≤ 0.05 and ns, not statistically
significant. When indicated, tests were performed on log10-
transformed data to homogenize the variances of the groups.
D’Agostino & Pearsons normality test was applied to test if log10-
transformed data within groups followed a Gaussian distribution.
Pearson’s correlation test was used to test for correlations
between cytokine levels in the DC supernatants.
Biocomputational analysis was performed on the PEA data
using the freely available web tool ClustVis (http://biit.cs.ut.ee/
clustvis/). Clustvis is written using R statistics software package
version 0.10.2.1 (15). The data was visualized using principal
component analysis (PCA). PC1 on the x axis was displayed
vs. PC2 on the y axis. Furthermore, was a heatmap created for
further visualization using the settings for clustering distance
set to correlation, clustering method was average and the
tree ordering shows the tightest cluster first for both rows
and columns.
RESULTS
Loss of IL-12p70 Associates With IL-10
Release During Long-Term Exposure to
Inflammation
Immature MoDCs were thawed on day zero and incubated in
medium with GM-CSF and IL-4. When indicated, inflammatory
agents were added to the DCs and on day four, all DCs and
supernatants were collected and subjected to further analysis. No
significant differences between the levels of IL-12p70 measured
on day 1, 2, and 3 were observed (Figure 1A) and whereas
the absolute levels of IL-12p70 varied from donor to donor,
the kinetics were equivalent among donors (Figure S1A). A
significant reduction of IL-12p70 (mean 91%, p < 0.0001) was
observed between day 3 and 4 (Figure 1A). In contrast, IL-10
only dropped moderately between day 1 and three, followed
by a six-fold increase on day 4 (p < 0.0001) (Figure 1B and
Figure S1B). Further, while donor-specific levels of IL-12p70
and IL-10 in supernatants from 1-day activated DC1s were
positively correlated (p < 0.05) (Figure 1C), they were inversely
correlated in supernatants from 4-day activated DC1s (p <
0.05) (Figure 1D). This strongly suggests de novo production
of IL-10 following long-term activation of DC1s. CD1a+
MoDCs have been described as main producers of IL-12p70
and allthough highly donor-dependent, typically account for
about 50% of cells in fetal bovine serum-supplemented culture
conditions (14). Thus, iDCs were sorted into CD1a+ and CD1a−
fractions and activated for 1 or 4 days. Interestingly, whereas
CD1a+ 1-day activated DC1s were main producers of IL-12p70,
CD1a− four-day activated DC1s were main producers of IL-10
(Figures 1E,F). Strikingly, CD1a+ and CD1a− fractions differed
substantially in their morphology. Whereas, maturing CD1a+
DCs maintained a rounded shape, CD1a− DCs seemed more
adherant and had a spindle-shaped morphology (Figure 1G).
Finally, phenotypic analysis of DC1s revealed that expression
of costimulatory molecules CD80 and CD86 increased over
the course of activation while being down regulated on 4-
day activated DC1s (Figures 1H,I). This expression pattern was
similar for all donors (n = 5) except one, where CD80 and
CD86 expression further increased on four-day activated DC1s.
Additional ELISA analysis of IL-12p40, IL-23, TNFα, and IL-
6 from DC supernatants aligned with IL-12p70 in terms of
decreasing levels observed in supernatants from four-day DC1s
albeit in the case of TNFα and especially IL-6 at less striking
changes (Figures S1C–F).
Four-Day Activated DC1s Efferocytose
Apoptotic DCs
We further characterized the consequences of prolonged
exposure of DCs to inflammation. Interestingly, the
morphological appearance of 4-day activated DC1s exhibited
clear signs of apoptosis (Figure 2A). These included classical
hallmarks of apoptosis, such as smaller cell size due to cellular
shrinkage and increased amounts of cell debris (16). In
contrast to 1-day activated DC1s, 4-day activated DC1s no
longer formed extensive dendritic projections. To confirm
these observations, DCs were stained with Annexin V and
7-amino-actinomycin D (7-AAD), allowing for detection of
early and late apoptotic events, respectively. In contrast to
all other samples, a large fraction of 4-day DC1s appeared as
pre-apoptotic Annexin V positive 7-AAD negative cells, while
no major differences were seen for late apoptotic (7-AAD
positive) and live DCs (Figure 2B). A systematic evaluation
of DCs from six donors stained with a fixable viability dye
revealed a significantly (p< 0.001) reduced amount of live 4-day
activated DC1s out of total cellular events (Figure 2C). Thus,
apoptosis associates with major changes in the IL-12p70 and
IL-10 concentrations in the DC culture supernatant following
long-term exposure to LPS and IFNγ . To further understand
why cytokine levels changed dramatically on day 4 of activation,
the influence of efferocytosis and TAM receptors was evaluated.
Interestingly, dual blockade potently inhibited the release
of IL-10 on 4-day activated DC1s (Figure 2D) but did not
impact levels of IL-12p70 (Figure 2E). Furthermore, while
TAM receptor blocade reduced the induction of apoptosis in
4-day activated DC1s, single blockade of efferocytosis seemed
to enhance the induction of apoptosis (Figure 2F). Indeed,
previous studies have linked efferocytosis to production of
immunosupressive molecules such as IL-10 and PGE2 (17),
but this has not been documented over a time course of
DC activation.
Long-Term Activated DCs Induce
Progressively Lower IFNγ Secretion From
Alloreactive T Cells
To examine if pro-longed exposure of DCs to inflammation
would affect the functionality and ability to induce cell
activation, DC1s were stimulated with allogeneic peripheral
blood mononuclear cells (PBMCs) in a MLR setup. After 5 days,
IFNγ was quantifyed as a measure of alloantigen-specific cell
activation. Extending DC1 activation for 2 or 3 days prior to
co-culture resulted in a progressive reduction in IFNγ (p <
Frontiers in Immunology | www.frontiersin.org 4 November 2019 | Volume 10 | Article 2702
Carstensen et al. Long-Term Inflammation Affects Dendritic Cells
FIGURE 1 | Cytokine and co-stimulatory receptor alterations during extended maturation of DCs. Immature DCs activated with the DC1 (LPS + IFNγ ) cocktail were
harvested after 1 (18 h), 2, 3, or 4 days (DC1-1d, DC1-2d, DC1-3d, DC1-4d). Immature DCs (iDCs) and sDCs, stimulated with the gold standard activation cocktail
(TNFα + IL-1β + IL-6 + PGE2 ) for 1 day (18 h), were included for comparison. The concentrations of (A) IL-12p70 and (B) IL-10 were measured in the DC
supernatants. Cumulative data are shown from five independent experiments with seven unique donors in total (n = 9). Bars represent mean + standard deviation.
The lower limits of detection were 7.8 pg/mL for IL-12p70 and 94 pg/mL for IL-10. Two-way ANOVA with Tukey’s post-hoc test was performed on log10-transformed
data to compare DC1 groups where ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01, and ns, not statistically significant. Pearson’s correlation test, where *p ≤ 0.05, was
used to test for correlations between the level of IL-12p70 and IL-10 measured in the DC1 supernatants on day 1 (C) and day 4 (D) of maturation. X-axis is shown on
a base 10 logarithmic scale. Levels of IL-12p70 (E) and IL-10 (F) is shown from 1- or 4-day activated CD1a+ and CD1a− sorted fractions of iDCs (n = 2) and
morphology of each day 4 DC1 subfraction is shown (100X magnification) (G). CD80 (H) and CD86 (I) expression is shown as cumulative data for five-six donors from
two-four independent experiments (n = 5–6). Data are presented as MFI ratios (stained sample MFI/unstained sample MFI). Two-way ANOVA with Tukey’s post-hoc
test was performed on the data to compare DC1 groups where ****p ≤ 0.0001, ***p ≤ 0.001, **p ≤ 0.01, and ns, not statistically significant. Bars represent mean +
standard deviation.
0.05). Notably, 4-day activated DC1s induced a nine-fold lower
IFNγ response (p < 0.001) compared to three-day activated
DC1s (Figure 3A). ELISA measurements of IL-12p70, IL-10
and IL-17A revealed similar response-patterns between sample
groups albeit at much lower absolute levels (Figures S2A–C). A
comparable and dose-dependent pattern was observed, when the
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FIGURE 2 | Apoptosis is induced in DCs after 4 days of activation with LPS and IFNγ . (A) Morphology of 1- and 4-day activated DC1s (400X magnification). Four-day
activated DC1s exhibit clear signs of undergoing apoptosis such as cell shrinkage and increased amounts of cell debris. Photographs are representative of six donors
(n = 6). (B) Apoptotic DCs were detected by staining with Annexin V and 7-AAD and percentages of live, pre-apoptotic, and dead cells is shown. The data is
representative of three independent experiments with four donors (n = 4). (C) Viability of DCs as a LIVE/DEAD Fixable Near-IR Stain negative percentage of FSC and
SSC gated cells. Four-day activated DCs were cultured in the precense of specific inhibitors targeting TAM receptor signaling (iTAM) and/or efferocytosis (iEffero). (D)
IL-10 and (E) IL-12p70 was measured in the supernatants and (F) the viability of DCs was measured with LIVE/DEAD Fixable dye. Cumulative data are shown from
two independent experiments with four donors (n = 4). Bars represent mean + standard deviation. Two-way ANOVA with Tukey’s post-hoc or Dunnett’s multiple
comparisons test was performed on non-transformed data to compare groups (****p ≤ 0.0001, **p ≤ 0.01, and ns, not statistically significant).
number of DCs in co-culture was titrated down from 10.000 to
5.000 and 2.500 DCs (Figure S2D).
Bulk PBMCs are easily obtained and contain several
lymphocyte fractions as well as myeloid cells. Thus, isolated
fractions of allogeneic CD4+ or CD8+ T cells were used
in an equivalent five-day co-culture setup. Indeed, similar
IFNγ response patterns as with PBMCs were observed for
both cell types (Figure 3B). This suggested that both T cell
populations were contributing to the IFNγ release observed
in Figure 3A.
In a previous study it was shown that DCs activated with
LPS and IFNγ for 21–27 h could regain IL-12p70 secretion
when activated by T cells in co-culture (18). To examine the
functional importance of IL-12p70 in our setup, a neutralizing
antibody against IL-12p70 or recombinant human IL-12p70
was added to the co-cultures. Addition of anti-IL-12p70 to
co-cultures with 1-, 2-, or 3-day activated DC1s resulted
in a 12-fold decrease in the IFNγ measured in the MLR
supernatants after 5 days (Figure 3C). This confirmed the
role of IL-12p70 as an IFNγ response inducer (19). In line,
addition of recombinant IL-12p70 to immature DCs but not
cultures without DCs, increased the release of IFNγ to the level
observed with 1-day activated DC1s. Conclusively, long-term
activation (4 days) of DC1s impair their functionality and lack
of IL-12p70 secretion results in non-functional T cells devoid
of IFNγ.
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FIGURE 3 | IFNγ release from co-cultures with long-term activated DCs is reduced. (A) DCs were activated with the DC1 maturation cocktail (LPS and IFNγ ) for 1, 2,
3, or 4 days (DC1-1d, DC1-2d, DC1-3d, DC1-4d) prior to being set up in co-culture with allogeneic PBMCs at a 1:10 ratio. After 5 days, IFNγ release was measured
in the MLR supernatants with a lower limit of sensitivity of 156 pg/mL. Co-cultures with iDCs and sDC were included for comparison. Cumulative data are shown from
five independent experiments with nine unique donor pairs in total (n = 9), consisting of seven DC donors and five PBMC donors. All experiments were performed in
quadruplicates. Bars represent mean + standard deviation. Two-way ANOVA with Tukey’s post-hoc test was performed on log10-transformed data to compare DC1
groups (****p ≤ 0.0001, **p ≤ 0.01, *p ≤ 0.05, and ns, not statistically significant). (B) Same as (A), except isolated CD4+ and CD8+ T cells were used as responder
cells instead of PBMCs. Data from three donors (n = 3) are normalized to highest value of IFNγ release within each donor. Bars represent mean + standard deviation.
Two-way ANOVA with Tukey’s post-hoc test was performed on normalized data to compare DC1 groups (****p ≤ 0.0001, **p ≤ 0.01, *p ≤ 0.05). The lower limit of
IFNγ detection was 39 pg/mL. (C) Co-cultures were set up as in (A) and supplemented with anti-IL-12p70 or recombinant human IL-12p70. Recombinant human
IL-12p70 was also added to cultures of PBMCs without DCs (w/o DC). After 5 days, IFNγ release was measured. Cumulative data are shown from one experiment
with three unique donors (n = 3). Bars represent mean + standard deviation.
Prolonged Stimulation With LPS and IFNγ
Induces Release of Multipe Inflammatory
Proteins
Finally, it was investigated if global changes in protein release
from the stimulated DCs accompanied the decrease in IL-
12p70 and increase in IL-10 observed on day 4. Undiluted DC
supernatants were analyzed in a multiplex immunoassay
(Proximity Extension Assay, PEA) with a panel of 92
inflammation-related proteins (Proseek Multiplex Inflammation
I). Five paired supernatants from each of the DC1 groups, one-
day, three-day and four-day (DC1-1d, DC1-3d, and DC1-4d), as
well as three supernatants from two-day DC1s (DC1-2d), were
analyzed. Three matched samples from immature DCs (iDCs)
and sDCs and a control medium sample were also analyzed.
Matched ELISA and PEA data from four proteins (IL-10, TNFα,
IL-6, and IL12p40) was used to compare the two methods.
Overall, data within the lower and upper limit of quantitation
(LLOQ and ULOQ) was comparable and highly correlated
as seen for IL-10 and TNFα (Figures S3A,B). However, due
to saturation, PEA measurements of IL-6 and IL-12p40 above
ULOQ did not correlate with ELISA results (Figures S3C,D). For
this reason, and because PEA was optimized to measure proteins
in plasma and serum, a total of 17 proteins were excluded from
analysis due to saturation (values above ULOQ) on a subset of
samples. Furthermore, in the case of 20 proteins, more than
80% of samples were below limit of detection and was therefore
excluded. To avoid over-interpretation, five additional proteins
with values around limit of detection were excluded leaving
50 proteins for interpretation. Principle component analysis
(PCA) was employed to assess relatedness between samples on
normalized sample data. All six control samples of iDCs and
sDCs clustered separately from all DC1 samples. Additionally,
another cluster of all 4-day DC1 samples was separate from
the remaining DC1 samples (Figure 4A). To assess significant
changes in protein levels during prolonged stimulation with
LPS and IFNγ, the matched samples from five donors were
analyzed by two-way ANOVA comparing one, 3 and 4 days
of stimulation. Significant variations (p < 0.05) were found
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FIGURE 4 | Long-term exposure to inflammation induces differential cytokine patterns in dendritic cells. (A) Principle component analysis of 50 detectable proteins
measured in culture supernatants from DCs activated with the DC1 activation cocktail (LPS and IFNγ) for 1, 2, 3, or 4 days (DC1-1d, DC1-2d, DC1-3d, DC1-4d).
Immature DCs (iDCs) and sDCs, stimulated with the gold standard activation cocktail (TNFα + IL-1β + IL-6 + PGE2 ) for 1 day (18 h), were included for comparison.
Supernatant from three-five donors was included in the analysis (n = 5 for 1-, 3-, and 4-day activated DCs). (B) Dendrogram depicting hierarchal clustering and heat
map analysis of normalized levels of 21 proteins found by two-way ANOVA to significantly differ between five matched samples from 1-, 3-, and 4-day activated DC1s.
(C) Six proteins that besides IL-10 was also strongly upregulated in 4-day activated DC1s. Two-way ANOVA with Tukey’s post-hoc test was performed to compare
DC1 groups where ****p ≤0.0001, ***p ≤0.001, **p ≤0.01, *p ≤0.05.
for 21 out of 50 proteins measured. To further understand
how these 21 proteins differed between samples, a heatmap
was generated displaying hierarchical clustering of normalized
values from all samples. Four groups of proteins were found of
which two groups included proteins upregulated in four-day
DC1s (Figure 4B). Interestingly, one of these groups was also
induced by sDC activation. Aside from IL-10 (Figure S3E), six
other proteins were strongly upregulated (p < 0.01) in four-day
DC1s including three proteins co-induced by sDCs (VEGF-A,
MMP-10 and CXCL6) as well as CDCP1, SLAMF1, and ADA
exclusively induced in 4-day DC1s (Figure 4C). The difference
in cytokine expression profiles of the different activation stages
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shows a striking change from 2- to 4-day DC1s (Figure 4B).
In conclusion, prolonged exposure to inflammation correlated
with a higher release of several inflammation-related proteins
from DCs, which was significantly different from short-term
activated DCs.
DISCUSSION
Taken together, we show that long-term exposure to LPS and
IFNγ affects the phenotype, cytokine production, cell activating
capacity and viability of human MoDCs. Most strikingly, 4-day
activated DC1s undergo apoptosis concomitant with a profound
induction of efferocytosis and TAM receptor-dependent IL-10
and an inversely associated drop in IL-12p70 as well as other pro-
inflammatory cytokines. Most notably, we show that upon long-
term inflammation, IL-10 seems to be primarly produced by the
CD1a− subfraction of DC1s whereas levels of IL-12p70, initially
produced upon short-term activation by primarily CD1a+ DC1s,
is now inversible correlated. Further work is needed to elucidate
if these subfractions are actively interacting e.g., during the
process of efferocytosis or if transcriptional programs governing
early IL-12p70 and late IL-10 release are independent processes.
The striking difference in morphology is also noteworthy as
spindle-shaped MoDCs is a well-known in vitro phenomena
dependent on activation with IFNγ (20). In our experience,
fraction of spindle-shaped DCs seems donor-dependent and
to our knowledge have not been dictomized between CD1a−
and CD1a+ subfraction in prior studies. Secretion of anti-
inflammatory cytokines, such as IL-10, is one of several ways, by
which the immune system can limit an inflammatory response,
induce tolerance and thereby inhibit reactivity toward self (21).
IL-10 is produced by many immune cells of both the innate
and adaptive immune system. In DCs, activation with LPS
and other TLR ligands induces concurrent production of IL-
12 and IL-10, the latter serving as a myeloid checkpoint to
avoid immunopathology (22). IL-10 has an inhibitory function
on IL-12, as it down-regulates the transcription of both p40
and p35 (23) and autocrine production of IL-10 down-regulates
the expression of surface co-stimulatory molecules and limits
production of IL-12 and TNFα (22). However, our study appears
to show that such autocrine signaling does not occur in this
prolonged DC activation setting possibly due to lack of re-
activating signals e.g., CD40L stimulation (18) allowing de novo
synthesis of IL-12p70. Thus, additional yet unkown mechanism
of actions may account for the subtle drop in proinflammatory
cytokine levels that accompany the release of IL-10.While, TAM-
receptor blockade increased viability and reduced levels of IL-
10, blocking efferocytosis did not improve viability of long-
term activated DCs. Interestingly, however our data support the
combination of both drugs for efficient blockade of IL-10 and
thus may add to new data suggesting benefit from combining
TAM-receptor blockade and PD-1 blockade in syngenic mouse
tumor models (24).
Programmed cell death of DCs is a regulatory mechanism,
which can be promoted by several factors, such as IL-10
and LPS (25). Along with being associated with impaired DC
activation and function, the tumor microenvironment has also
been shown to induce apoptosis in DCs (26). Interactions with
apoptotic cells can induce differentiation of immature DCs into
tolerogenic DCs that secrete IL-10 and induce regulatory T cell
(Treg) differentiation. An early study showed that incubation of
monocytes with apoptotic cells during activation with LPS led to
increased secretion of IL-10 and decreased secretion of TNFα and
IL-1β (27). Later, it was described that phagocytosis of apoptotic
DCs by immature DCs primes them to become tolerogenic and
promote development of induced Tregs from naïve T cells (28).
Here, we found that IFNγ was progressively lost as exposure
of the DC1s to inflammatory stimuli was extended from 1 up to
4 days prior to MLR co-culture. Particularly, the IFNγ response
was reduced nine-fold in co-cultures of allogeneic PBMCs with
DCs activated for four compared with 3 days. Antibody-mediated
blockade of IL-12p70 resulted in a similar reduction in IFNγ,
verifying the functional relevance of DC-secreted IL-12p70 in
induction of IFNγ.
Finally, we employed multiplex analysis of DC supernatants
to further understand the changes induced in DCs following
long-term inflammation. We took advantage of ClustVis, a freely
available web tool for visualizing clustering of multivariate data
using PCA and heatmaps (15). We found that PCA analysis
separated 4-day activated DC1s from the remaining 1, 2, or
3-day activated DC1s. Furthermore, all five samples from 4-
day activated DC1s formed a separate cluster from remaining
DC1s in the heatmap, and expressed increased levels of eight
proteins (CDCP1, PD-L1, TNFRSF9, SLAMF1, ADA, LIF, IL-
1α, IL-10). These proteins are involved in a broad range of
functionalities related to apoptosis, cancer and conditions of
chronic inflammation. Thus, CDCP1 is a novel marker of
the most aggressive human triple-negative breast cancers (29).
PD-L1 is a well-known cancer immune checkpoint that when
silenced in DCs augments expansion and function of antigen-
specific T cells (30). SLAMF1 is overexpressed in myeloid
cells from patients with Crohn’s disease and in T lymphocytes
from patients with rheumatoid arthritis (31). In regards to
apoptosis, TNFRSF9 or 4-1BB acts as a survival factor in DCs
(32) and the enzyme ADA abrogates the anti-inflammatory
effects of adenosine present in apoptotic supernatants (33). IL-
1α is a proinflammatory cytokine induced during pyroptosis,
involving plasma-membrane permeabilization of macrophages
and DCs upon LPS stimulation and downstream caspase-
1 and inflammasome activation (34). In conclusion, proteins
upregulated in 4-day activated DC1s identify features that
associates with induction of apoptosis and associates with
conditions of cancer and chronic inflammation.
Furthermore, another cluster of proteins comprising VEGF-
A,MMP-10 and CXCL6 was upregulated in 4-day activated DC1s
as well as non-functional sDCs activated by PGE2, TNFα, IL-
1β, and IL-6. VEGF-A confined to lymph nodes is primarily
produced by DCs (35) and activation by anti-inflammatory
molecules such as calcitriol, PGE2, or IL-10 has been shown
to induce production of VEGF-A (36). Interestingly, PEA
analysis of plasma from metastatic melanoma patients treated
with immune checkpoint inhibitors showed association between
both VEGF-A and IL-10 and shorter progression free survival
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(37). In a vaccination setting, MMP-10 was critical for in
vivo tolerance and release of IL-10 and TGFβ1 upon repeated
cutaneous exposure to the TLR7 agonist, Imiquimod (38).
CXCL6 is a neutrophil chemoattractant associated with chronic
inflammation and predominantly produced inmesenchymal cells
stimulated with IL-1β and counteracted by IFNγ (39). Conditions
of IL-1β and hypoxia also promotes CXCL6 in cell lines from
small cell lung cancer (40). In conclusion, VEGF-A, MMP-10,
and CXCL6 share features of non-functional, anti-inflammatory
tumor-promoting markers that may be induced upon selected
stimuli. Prior data had already documented a skewed chemokine
pattern, in which DC1 primarily produce abundant levels of pro-
inflammatory CXCL10 andCCL5 as opposed to sDCs thatmainly
secreted Treg attracting CCL22 (41). These new findings thus
further underscore the disadvantages of using sDCs for cancer
vaccination approaches. Instead we suggest that short-term
activated DC1s represent a desired state of acute inflammation,
whereas sDCs and long-term activated DC1s represent a state of
chronic inflammation often found during chronic viral infection
and cancer.
To summarize, long-term activated DC1s dramatically
changed their cytokine secretion profile toward a tumor-
promoting and anti-inflammatory phenotype. After 4 days
of activation, DC1s became apoptotic and non-functional,
highlighting the difference between acute and chronic states
of inflammation.
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